KOL Lunch: Novel Treatments in Non-Small Cell Lung Cancer, hosted by OSE Immunotherapeutics (OSE.PA)

The meeting will feature a presentation by key opinion leader Benjamin Besse, MD, PhD (Paris-Sud University), who will discuss the current treatment landscape and unmet medical need in patients with thoracic cancers, including non-small cell lung cancer (NSCLC).